MARGARET SLAGLE: Open Payments
NPI 1164951117 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 33 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $132 · 2025 $755
Food & beverage: $655Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $137 |
| Incyte Corporation | 1 | $100 |
| Janssen Biotech, Inc. | 3 | $63 |
| Eisai Inc. | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| GENZYME CORPORATION | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| PFIZER INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: Enhertu, DATROWAY, Lenvima, Nubeqa, SARCLISA, SCEMBLIX, OJJAARA, XYNTHA.
Industry payments across MO — which companies pay providers there.
